Owkin

Collaborative research platform and unique AI drug development solutions that make precision medicine a reality

Launch date

Sep 2016

Employees

Ownership

Firm valuation

New York City New York (HQ), Paris Île-de-France (founding location)

Date	Investors	Amount	Round
-	Cathay Capital Otium Capital Plug & Play Topeka	N/A	- Not yet verified
Oct 2016	Brent Hoberman Jörg Mohaupt Shana Fisher NJF Capital Nicole Junkermann Jean-Paul Clozel	$2.1m	Seed
Jan 2018*	Frst Cathay Innovation NJF Capital Plug and Play	$11m	Series A
May 2018	GV	€4.2m	Series A
Mar 2019	Eight Roads Ventures GV Cathay Innovation NJF Capital F-Prime	N/A	Series A
May 2019*	GV Cathay Innovation NJF Capital F-Prime	€13m	Early VC
May 2020*	Eight Roads Ventures Bpifrance GV Cathay Innovation F-Prime MACSF	$25m	Series A
Jul 2020	Bpifrance Mubadala Capital Ventures	$18m Valuation: $125m	Series A
Jul 2021	EIT Health e.V.	N/A	Grant
Nov 2021*	Sanofi	$180m Valuation: $1.0b	Growth Equity VC
Jun 2022*	Bristol-Myers Squibb	$80m Valuation: $1.0b	Series B
Total Funding		$335m

Tech stackLearn more about the technologies and tools that this company uses.

Owkin funding